Đốt nhiệt sóng cao tần trong điều trị ung thư biểu mô tế bào gan tại Cần Thơ năm 2021 – 2023

Radiofrequency ablation is one of the radical treatments for early-stage hepatocellular carcinoma. In Can Tho, radiofrequency ablation has been implemented in several hospitals, however there are not many studies that fully evaluate the treatment results. Objectives: 1) To determine clinical and subclinical features of hepatocellular carcinoma; 2) To evaluate the treatment results for hepatocellular carcinoma by radiofrequency ablation at Can Tho Central General Hospital, Can Tho Oncology Hospital and Can Tho University of Medicine and Pharmacy Hospital. Materials and methods: This was a prospective, cross-sectional study on 42 patients with hepatocellular carcinoma who were treated with radiofrequency ablation. Results: The mean age of the patients: 63 ± 10 years old. Male/female: 2.5/1. Median of AFP: 8.49 ng/mL. The mean tumor size: 2.75 ± 0.96 cm. Mean number of ablations for each tumor: 1.7 ± 1.3 times. Mean time of ablation for each tumor: 24.8 ± 14.5 minutes. Overall complication was 4.8%. The mean duration of hospital stays: 1.5 ± 0.9 days. The rate of complete necrosis of the tumor after 1 month was 85.1%. The complete response after ablation at 1 month, 3 months, 6 months and 12 months was 83.3%, 80.5%, 80.6% and 68.2%, respectively. The 1-year survival rate was 87.5%. Conclusion: Radiofrequency ablation of hepatocellular carcinoma is safe and effective